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Metabolic effects of exercise training in hemodialysis patients.
The effects of 9 6 months of exercise training on lipid and
carbohydrate metabolism were studied in six hemodialysis pa-
tients. Training lowered triglyceride levels 39 25% (P < 0.02)
and increased plasma high-density lipoprotein cholesterol levels
23 22% (before, 26 5 mg/dl; after, 31 8 mg/dl; P < 0.05).
There was a 23% improvement in glucose tolerance (P < 0.01)
and a 40% reduction in hyperinsulinism (P <0.01) with no signif-
icant changes in body weight or diet. There was a 25 8% in-
crease in hematocrits (before, 22 2%; after, 27 2%,P <0.01)
and a 29 22% rise in hemoglobin concentrations (before, 7.0
0.8 gldl; after, 9.0 0.6 gIdl, P < 0.04) in five patients. In addi-
tion, during training antihypertensive medications could be re-
duced in three patients with maintenance of normal blood pres-
sure. The improvements in lipid and carbohydrate metabolism
diminished when two patients stopped training. These results
suggest that physical training can improve some of the metabolic
abnormalities observed in hemodialysis patients and could be im-
portant as a therapeutic modality.
Effets métaboliques de l'entrainement physique chez les malades
en hémodialyse. L'effet de 9 6 mois d'entraInement physique
sur le metabolism des lipides et des hydrates de carbone a été
étudié chez 6 malades en hémodialyse. L'entrainement a abaissé
les concentrations de triglycerides de 39 25% (P < 0,02) et
augmenté les concentrations de HDL de 23 22% (pré, 26 5
mg/dl; post, 31 8 mg/dl; P < 0,05). Il y eu une amelioration de
23% de Ia tolerance au glucose (P < 0,01) et une diminution de
40% de l'hyperinsulinisme (P < 0,01) sans modification signifi-
cative du poids corporel ou du regime. L'hématocrite a aug-
menté de 25 8% (pré, 22 2%; post, 27 2%;P <0,01)et une
augmentation de 29 22% de Ia concentration d'hémoglobine
(pré, 7 0,8 g/dl; post, 9 0,6 gldl; P <0,04) chez cinq mala-
des. De plus, Ic traitement antihypertenseur a pu étre réduit chez
trois malades, Ia pression artérielle s'est maintenue dans des Va-
leurs normales. Les ameliorations des mdtabolismes des lipides
et des hydrates de carbone ont disparu chez deux malades qui
ont arrété leur entraInement. Ces résultats suggèrent que
l'entraInement physique peut améliorer certaines anomalies me-
taboliques observCes chez les malades en hemodialyse et peut
être une modalitd therapeutique importante.
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Patients with end-stage renal disease who require
maintenance hemodialysis frequently exhibit abnor-
malities in lipid and carbohydrate metabolism [1-4],
have hypertension [5], and develop atherosclerosis
[6—7]. Many of these metabolic abnormalities accel-
erate atherosclerosis and its sequellae in hemo-
dialysis patients [6—8]. Exercise training modifies
coronary risk factors by improving endocrine-meta-
bolic abnormalities in nonuremic individuals. These
include a reduction in plasma triglyceride levels [9-
11], an increase in plasma high-density lipoprotein
cholesterol concentrations [10, II], an improve-
ment in carbohydrate tolerance [12-14], and a de-
crease in high blood pressure levels [15, 16]. This
study was designed to determine whether exercise
training would have similar beneficial effects on
these risk factors for coronary heart disease in he-
modialysis patients.
Methods
Patient selection. Six patients requiring hemo-
dialysis for 4 to 6 hours three times weekly to treat
end-stage renal disease were studied (Table 1). All
provided informed consent. All had anemia and re-
duced plasma high-density lipoprotein cholesterol
levels and received aluminum hydroxide, calcium
carbonate, ferrous sulfate, and multivitamins at a
stable dose. The men received norandrenalone ace-
tate (100 mg every 2 weeks). Five males had hyper-
triglyceridemia, and four required drug treatment to
control hypertension (Table 1). Two patients (3 and
6) were anephric, and all were oliguric (creatinine
clearance of less than 1 ml/min). Patient 1, who
smoked cigarettes (20 cigarettes/day) prior to train-
ing, discontinued smoking after 7 months of partici-
pation.
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Table 1. Clinical characteristics of study patients
Duration
Patient
no. Age/sex Diagnosisa
Body wt/height
kg/cm
hemodialysisb
months Complicationse Medication
1 31/M GN 68.3/183 23 HI, Cardiomegaly
Angina pectoris
Propranolol (280 mg/day)
Hydralazine (350 mg/day)
2 32/M GN 149.5/209 48 HT, Cardiomegaly
CHF, TX (2)
Prazosin (4 mg/day)
Digoxin (0.125 mg/day)
3 26/F GN 53.2/155 42 Anemia, PTX,
TX(2)
—
4 45/M GN 77.5/180 55 TX(2) —
5 42/M HT 95.7/183 23 HT, cardiomegaly Propranolol (160 mg/day)
Hydralazine (400 mg/day)
6 48/M Cancer 74.1/174 21 HT, cardiomegaly Clonidine (0.4 mg/day)
Prazosin (12 mg/day)
Mean 37.3 35.3
14.8
a GN is glomerulonephritis; HT, hypertension; Cancer, renal cell carcinoma.
Months on hemodialysis prior to exercise training.
HI is hypertension; CHF, congestive heart failure; TX, kidney transplant; PTX, parathyroidectomy.
Patients were selected to participate if: (a) they
had no medical problems which contraindicated ex-
ercise training, such as ventricular arrhythmias,
poorly controlled hypertension, or diabetes mellitus
with severe retinal disease and/or neovasculari-
zation, unstable angina pectoris, hemodynamically
significant cardiac valve lesions, congestive heart
failure, or severe renal osteodystrophy; (b) they
were on a stable medication regimen, diet, and
dialysis schedule and their interdialysis serum
chemistries, blood pressures and hematocrits were
stable for at least 6 months prior to study,
to guard against the possibility that the changes
that occurred during training could be attributed
to factors other than exercise; and (c) they were
motivated to participate. Their primary renal di-
agnosis was determined clinically or by biopsy,
and none had hypothyroidism or diabetes mellitus
(Table 1).
Data on a 31-year-old male (173 cm, 57 kg) with
insulin-dependent diabetes mellitus of 15 years' du-
ration, who has been exercising on his own for 42
months, are also reported. He has received two un-
successful renal transplants and has required main-
tenance hemodialysis for 63 months. His current
medications include 14 U of NPH insulin and 8 U of
regular insulin in the A.M. and 10 U of NPH in the
P.M., calcium carbonate, ferrous sulfate (900 mg/
day), and multivitamins. He has been running 2 to 4
miles per day for 27 months.
Experimental design. Initial evaluations includ-
ed: (a) a complete examination by a cardiologist, (b)
a symptom-limited graded exercise treadmill test
according to the protocol of Bruce and Hornsten
[17], (c) a maximal oxygen consumption test [18],(d) two determinations of fasting plasma tri-
glyceride, cholesterol, and high-density lipoprotein
cholesterol concentrations and one measurement of
fasting lipoprotein lipid concentrations at least 1
month apart, and (e) the determination of the
plasma insulin and glucose responses to an i.v. glu-
cose tolerance test (20 g). Hematocrit, body weight,
and blood pressure were measured routinely at each
dialysis, and hemoglobin, blood urea nitrogen,
serum creatinine, calcium, phosphate, and albumin
were measured monthly. During training, plasma
total lipids and high-density lipoprotein cholesterol
concentrations were remeasured at 8 week inter-
vals, the cardiovascular evaluation and exercise
tests were repeated every 10 weeks, lipoprotein lip-
id concentrations were remeasured every 12 weeks,
and i.v. glucose tolerance tests were repeated every
16 weeks. To control for the degree of uremia and
the metabolic effects of heparin, we performed all
tests 36 hours after the previous dialysis.
Patients followed their prescribed renal diet dur-
ing the training program and were instructed to
maintain their weight. Food intake was increased
keeping diet compositions proportionate, to com-
pensate for the energy expenditure during training
to prevent weight loss. Patients were counseled to
insure consistency, and careful diet recalls were
performed in two patients (1 and 4).
The training protocol was similar to that de-
scribed for the rehabilitation of ischemic heart dis-
ease patients [19] except that initial training in-
tensities were lower and the progression slower due
to the reduced exercise capacity in these dialysis
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Table 2. Effects of exercise training on lipid metabolisma
VLDL- LDL- HDL-
Duration TG VLDL-TG HDL-TG CHOL CHOL CHOL CHOL
•Patient
of
exercise mg/dl mg/dl mgldl mg/dI- mgldl mg/dI mg/dl
no. months Before After Before After Before After Before After Before After Before After Before After
1 18 279 194 193 123 15 18 200 175 68 59 103 86 24 34
2 11 457 147 7
(41)b (22)
12
154 104
(162)b
67 24
(88)"
68 44
(52)b
91
33 36
3 11 108
(3l2)t
130 52 15
(248)b (20)b
139 14911 (19l) 27 13(43)b 94(115)b 44(33)b
4 8 1248 540 1070 475 19 15 363 205 254 121 72 62 18 20
5 3 242 252 8 150 164 43 50 70 87
6 3e 312 172 167 86 12 16 238 227 58 49 156 149 25 29
Mean 9.0 452 236 364 173 16 13 207 171 86 53 93 87 26 31
SD ±5.7 ±401 ±157 ±365 ±155 ±5 ±5 ±85 ±43 ±84 ±38 ±34 ±36 ±5 ±8
pa <0.02 <0.02 NS NS NS NS <0.05
a Patient numbers correspond to Table 1. "Before" is before training (mean ± SD, 3 determinations), "After" is after training.
Abbreviations used are: TG, triglyceride; CHOL, cholesterol; VLDL, very-low-density lipoprotein; LDL, tow-density lipoprotein;
HDL, high-density lipoprotein.
b Five months alter cessation of training
Received kidney transplant
"Withdrew, nephrectomy
Statistical significance from before training
patients. All training sessions took place in a tem-
perature- and humidity-controlled facility contain-
ing a 17 lap per mile track and were supervised by a
physician, an exercise physiologist, and an exercise
technician trained in cardiopulmonary resuscita-
tion. Emergency medications and equipment, in-
cluding a defibrillator, were always present and
were used once to treat a cardiac arrhythmia.
Initial training began with light calisthenics fol-
lowed by two 5-mm exercise sessions on a bicycle
ergometer at a work rate designed to elicit 40% of
maximal oxygen consumption. Blood pressure and
heart rate and rhythm were monitored during the
exercise. At I month, depending on each partici-
pant's adaptation to the program, rapid walking was
added, and alternate periods of walking and jogging
were introduced when the patients were able to
train at 60% of their maximal oxygen consumption
on the bicycle. At 8 months, all patients were walk-
ing and jogging up to 2 miles per session and cycling
at 65 to 75% of their maximal oxygen consumption.
Patients 5 and 6 withdrew from the program for var-
ious medical reasons unrelated to conditions of the
study (Table 2), but their data are included in the
analyses because their work capacity improved dur-
ing the 3-month period of training. Patients 2 and 3
stopped endurance exercise training on a regular
basis after 11 months of participation in the pro-
gram. After 5 months of no training, their lipids and
carbohydrate metabolism were reevaluated.
Analytical methods. Plasma triglyceride, choles-
terol, and lipoprotein lipid concentrations were de-
termined by Lipid Research Center techniques [20].
Plasma immunoreactive insulin was measured by
the method of Morgan and Lazarow [21] and plasma
glucose by the glucose oxidase method (Beckman
Instruments, Fullerton, California). Hematocrit,
hemoglobin, creatinine, phosphate, calcium, alka-
line phosphatase, albumin, and thyroid and liver
function were measured by standard autoanalyzer
techniques.
The glucose disappearance rates (kg, %/min)
were calculated from 10 to 60 mm during the i.v.
glucose tolerance test by the equation: kg = 0.693 ÷
tV2, where ti!2 is the time it took for glucose to de-
crease by 50% from its peak value. The insulin area
under the curve was computed by trapezoidal in-
tegration of the experimental curves from 0 to 120
mm after subtracting the basal insulin level. Fasting
insulin and glucose levels represent the mean ± SD
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of at least three separate determinations on the day
of the glucose tolerance test. All data are reported
as means SD.
Statistical methods. Data were analyzed by the
paired t test and the signed Rank test [22].
Results
Exercise testing. Initially, the graded exercise
treadmill test duration for these six dialysis patients
was shorter (332 105 see) and their mean maximal
oxygen consumption lower (18.1 3.7 ml 02/kgl
mm) than that commonly found in healthy seden-
tary people of the same age and sex (P <0.001) [23,
24]. After 9 6 months of training, the graded exer-
cise treadmill test duration had increased 41% (P <
0.02; Fig. 1) and there was an increase in the maxi-
mal oxygen consumption of everyone except pa-
tient 4 (22 21%, P < 0.10, N = 6, Fig. I). The
maximal oxygen consumption and graded exercise
treadmill test duration of the patient who has been
training on his own for 42 months were 34.5 ml 02/
kg/mm and 580 see, respectively. The maximal oxy-
gen consumption of patient 2 decreased by 12% af-
ter 5 months without training. Patient 3 did not re-
turn for retesting.
Lipid and carbohydrate metabolism. Training
was associated with a 39.2 24.8% reduction in
fasting plasma triglyceride levels (P < 0.02, Table
2), a 44.3 28.8% reduction in very-low-density
lipoprotein triglyceride concentrations (P < 0.02,
Table 2) and a 23.0 21.7% increase in plasma
high-density lipoprotein cholesterol levels (P <
0.05, Table 2). Patient 5 gained 3 kg during training
and did not demonstrate any of these changes. The
changes in both plasma triglyceride and high-den-
sity lipoprotein cholesterol levels were gradual and
maintained over the training period in the four pa-
tients who trained for longer than 3 months (Fig. 2,
A and B). The changes in the plasma concentrations
of the other lipoprotein classes during training were
variable, and not statistically significant (Table 2).
The cessation of exercise in patients 2 and 3 was
associated with a decrease in their plasma high-den-
sity lipoprotein cholesterol levels and a rise in the
triglyceride and cholesterol concentrations of the
other lipoprotein classes (Table 2).
Prior to training, all patients had normal fasting
plasma glucose levels and a normal glucose dis-
appearance rate (Table 3). In the five patients who
were retested, there was a 6.3 2.4% reduction in
fasting plasma glucose concentrations (P < 0.01)
and a 22.5 7.3% improvement in glucose dis-
appearance rates (P < 0.01, Table 3). Fasting
plasma insulin levels were high in these patients pri-
or to training and decreased 40.1 16.4% in the
patients retested after training (P < 0.01, Table 3).
Exercise training also resulted in a 38.0 21.8%
reduction in the integrated insulin areas calculated
above the fasting insulin levels during the i.v. glu-
cose tolerance test (P <0.02, Table 3). In patients 2
and 3, a cessation in training was associated with a
decrease in their glucose disappearance rates and
an increase in their insulin levels (Table 3).
There were no significant changes in these six pa-
tients' body weights (change, —0.13 1.8 kg) or
percent body fat (before, 17.8 8.6%; after, 17.8
7.1%) during training. The weight of the partici-
pants varied by less than 3 kg during the program
and did not correlate with the lipid changes. After
the cessation of regular training, patient 2 gained 4
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Fig. 1. Graded exercise treadmill stress test duration and maximal oxygen consumption before and after training.
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Fig. 2. Sequential effect of exercise training on A plasma triglyceride levels and B plasma HDL cholesterol levels.
kg, and patient 3 maintained a stable weight. Die-
tary recalls revealed a 13% increase in total calories
in patient 1 over a 15-month period of training and a
9% increase in calories in patient 4 over 6 months,
with small changes in the composition of both their
diets. In patient 1, the percentage of calories from
protein was 17% initially, 16% at 6 months, and 14%
at 15 months; fat represented 36% initially, 37% at 6
months, and 41% at 15 months; and carbohydrate
was 48%, 47%, and 45% of the calories, respective-
ly. In patient 4, the pretraining calorie distribution
was 18% as protein, 35% as fat, and 47% as car-
bohydrate; after 6 months it was 19% protein, 33%
fat, and 48% carbohydrate.
Hypertension. The antihypertensive medications
of three of the four hypertensive patients were re-
duced in dosage or discontinued during the training
program because of a decrease in blood pressure. A
normal blood pressure was maintained despite the
following reductions in medicines. Patient I: Hy-
dralazine was discontinued, propranolol reduced by
220 mg/day. Patient 5: Hydralazine was reduced
100 mg/day, clonidine reduced 0.2 mg/day. Patient
6: Prazosin was discontinued, clonidine reduced 0.2
mg/day. When patient 1 reduced his training effort
for 2.5 months, his blood pressure rose and anti-
hypertensive medication had to be reinstituted; a
return to a regular training schedule reduced his
blood pressure and permitted a reduction in the dos-
ages of his antihypertensive medication. Exercise
training also appeared to lower the blood pressure
of the patient who trained on his own for 3 years.
When he began dialysis therapy in 1974, he required
a-methyldopa (2 g/day), hydralazine (100 mg/day),
and propranolol (80 mg/day) for control of blood
pressure. With the maintenance of a regular exer-
Table 3. Effects of exercise training on glucose metabolisma
plas
Fasting
ma gluc
mgldl
ose
Glucose
disappearance
rate, %/min
pla
Fasting
sma ins
MImI
ulin
Integrated
insulin area
U/mlImin
Patient Before After Before After Before After Before After
1 88 83 1.71 2.12 24 11 3510 2820
2 108 99
(100)b
0.79 0.89
(0.82)'
88 37
(8Ø)b
3155 1036
(1860)b
3 86 80
(8O)b
1.31 1.73
(l6l)tI
23 17
(19)b
4480 2750
(2885)b
4 88 81 1.69 2.12 27 15 4080 2070
5 87 — 0.76 — 16 — 3680 —
6 82 80 1.57 1.86 14 11 2200 1890
Mean 90 85 1.31 1.74 32 18 3518 2113
SD ±9 ±8 ±0.44 ±0.51 ±28 ±11 ±792 ±728
PC <0.01 <0.01 <0.01 <0.02
a "Before" is before training; "After," after training.
Five months after cessation of training
Statistical significance from pretraining level
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cise program, his blood pressure has been in the
normal range for the last 12 months on 60 mg/day of
propranolol.
Anemia. All patients had low hematocrits (21.7
1.7%, N = 6) and hemoglobins (6.9 0.8 g/dl, N =
6) that varied by less than 2.0% for the 6 months
prior to training. The data on the effects of training
on anemia in the female patient were uninterpret-
able because she had regular menses and required
transfusions of 2 or 3 U per month. Therefore, they
are not included. In the five male patients who
trained for at least 3 months, there was a rise of 24.8
7.8% in hematocrits (before, 22.1 1.5%; after,
27.4 1.7%; P < 0.01, Fig. 3) and 29.0 21.5% in
hemoglobin concentrations (before, 7.1 0.8 g/dl,
after, 9.0 0.6 g/dl; P < 0.04; Fig. 3) during train-
ing, with no change in their dose of ferrous sulfate
or norandrenalone acetate. Their reticulocyte counts
and serum albumin concentrations were also un-
changed. There was also a rise in the hematocrit of
the patient who has been training on his own for 42
months. His hematocrit was 25% prior to training
and rose to 45% after 9 months of training. He now
runs 2 to 4 miles per day and maintains a hematocrit
of 42%, despite discontinuation of norandrenalone
acetate after 12 months of training.
Discussion
Results in this study demonstrate that some he-
modialysis patients have a very low work capacity
and that a moderate endurance training program
can improve both their exercise tolerance and some
of their endocrine-metabolic abnormalities. The
mean maximal oxygen consumption of dialysis pa-
tients in this study was lower than that of age- and
sex-matched sedentary normal controls, patients
with ischemic heart disease [25], or patients with a
chronic illness, such as diabetes mellitus [13, 14]. It
was also lower than that reported by Lundin et al
[26], in a somewhat younger group of dialysis pa-
tients. The reduced graded exercise treadmill test
duration found in our dialysis patients is consistent
with their low maximal oxygen consumption. Train-
ing resulted in a gradual improvement in both of
these tests, but levels still remained well below the
normal range. Despite the rather small increase in
maximal oxygen consumption, exercise training
was associated with improvements in glucose me-
tabolism and some parameters of lipid metabolism,
a reduction in hyperinsulinemia, a rise in hemato-
crit, and an attenuation of hypertension in some of
these patients. It is possible that other cointerven-
tions, such as changes in diet, body weight, ciga-
rette smoking, or other health-related habits, could
have occurred in these patients and influenced their
metabolism to some extent. But these were mon-
itored, and remained relatively constant. Further-
more, the metabolic changes that occurred in the
individual who stopped smoking were comparable
to the effects in other patients.
Exercise training was associated with a signifi-
cant increase in plasma high-density lipoprotein
cholesterol concentrations in the five patients in
whom plasma triglyceride levels decreased. In the
two patients who stopped training, plasma tri-
glyceride levels increased, and high-density lipo-
protein concentrations decreased to levels com-
parable to those observed prior to participation in
the program. The mechanism by which increased
physical activity lowers triglyceride and raises the
plasma level of high density lipoprotein cholesterol
in nonuremic man is thought to be mediated by an
exercise-induced increase in the activity of lipopro-
tein lipase [27]. Because the lipid abnormalities in
Exercise in hemodialysis 759
10
30
o 8
225
20 6
Initial Trained
Fig. 3. Effect of exercise training on hematocrit and hemoglobin levels in five male dialysis patients.
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dialysis patients are due to a reduction in the activi-
ty of this enzyme [28, 29], it is possible that these
lipid changes reflect an increase in the level of lipo-
protein lipase activity.
The elevation in plasma insulin may contribute to
the lipid disorder observed in dialysis patients by
promoting the synthesis and production of tri-
glyceride-rich lipoproteins by the liver [1, 2, 30].
Physical training improves insulin sensitivity and
glucose metabolism in normal individuals and adult
onset diabetics [11—13, 31], and results in this study
indicate that it will improve glucose metabolism and
reduce insulin resistance in hemodialysis patients.
If there is a reduction in the frequency and intensity
of training, however, these improvements diminish.
The magnitude of the changes in lipid and carbohy-
drate metabolism that occurred during training was
greater than would have been anticipated due to
changes in diet or body weight. It is also unlikely
that major changes in body composition occurred,
because body weights and percent body fats re-
mained constant in these patients. Although
changes in the dose of antihypertensive medications
could have contributed to the improvement in lipid
and carbohydrate metabolism observed in patients
1 and 6, these metabolic improvements also oc-
cuned in the three patients (2, 3, and 4) whose med-
ications were not changed during training. Further-
more, the return of plasma lipid levels, glucose dis-
appearance, and hyperinsul inemia toward pretrain-
ing levels in the patients who stopped training sug-
gests that the training effect was primary.
There was a reduction in the blood pressure of
three of the four hypertensive patients during the
training program, which permitted a reduction in
dosages of peripheral vasodilator types of anti-
hypertensive medications. This suggests that exer-
cise may lower blood pressure in some dialysis pa-
tients by reducing peripheral vascular resistance,
but exercise-induced changes in sodium-volume
homeostasis, the renin-angiotensin system, and the
sympathetic nervous system might also play a role
[32, 33]. There was also an increase in hematocrits
and hemoglobin concentrations of all the male dial-
ysis patients during training. These increases could
be due to hemoconcentration or changes in doses of
antihypertensive medications, rather than an exer-
cise-induced increase in red cell mass [34]. Hemato-
crit levels increased, however, in two patients (2
and 4) whose medications were not altered during
training. These increases in hematocrit and hemo-
globin seemed to be greater than would have been
expected due to changes in plasma volume alone,
because there were no significant changes in serum
albumin concentrations or postural hypotension to
suggest significant hemoconcentration. Determina-
tions of red cell mass and plasma volume are critical
for the resolution of these questions. Nevertheless,
even if the changes in blood pressure and/or hema-
tocrit levels are due to a reduction in the extra-
cellular fluid volume, they would be of clinical ben-
efit to dialysis patients whose fluid volume and
blood pressure are frequently difficult to control.
This study presents preliminary evidence that ex-
ercise training has the potential to ameliorate some
of the endocrine-metabolic abnormalities and coro-
nary risk factors in dialysis patients. Before training
programs can be initiated on a larger scale, further
investigation will be required to determine the opti-
mal training program for dialysis patients of dif-
ferent ages and disabilities, and to fully understand
the physiologic responses of these patients to train-
ing.
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